Home > Insider Trading > Filing (0000947871-13-000619)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326583	Webmd Health Corp.	WBMD	Services-Business Services, Nec (7389)	202783228

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1549889	B Michael Glick	111 Eighth Avenue New York NY 10011	Exec Vp And Co-General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-08-21	16,664	$21.29	49,698	No	4	M	Direct
Common Stock	Disposition	2013-08-21	13,444	$31.72	36,254	No	4	F	Direct
Common Stock	Disposition	2013-08-21	11,013	$31.78	25,241	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-08-21	16,664	$0.00	16,664	$21.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2018-12-10	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	383	Indirect	By 401(k) Plan

Footnotes

Mr. Glick received 3,220 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 16,664 shares of WebMD Common Stock, with the remaining 13,444 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.64 to $31.95 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
25% of the shares underlying the option vested on the first, second, third and fourth anniversaries of the date of grant (fully vested on the 4th anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date and to satisfy the minimum tax withholding requirements arising from the exercise.